GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for ribosomal lysine N-methyltransferase 5 (C7GMI9)

Analyse AlphaFold monomer V2.0 prediction for ribosomal lysine N-methyltransferase 5… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
C7GMI9
Type
protein
Length
367 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x9073C46348542FfE4327c3F363F9B51B22058e75
Molecule
Ribosomal lysine N-methyltransferase 5
UniProt
C7GMI9
Pockets
3 · best druggability 0.66

Structure

1 distinct chain · 33% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARibosomal lysine N-methyltransferase 5protein36733% helix, 22% strandC7GMI9

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1540.660.9619empty
2700.300.7314empty
3590.300.7514empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.